Clinical trial · Observational
Endometrial Malignancy in Breast Cancer Patients With or Without AUB
Ultrasonographic, Hysteroscopic, Histopathologic Findings and Risk of Endometrial
NCT05977829CI-TRIAL-00072522TamAUBcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In order to assess the hysteroscopic, histopathologic, and ultrasonographic aspects of uterine monitoring in postmenopausal breast cancer patients with or without abnormal uterine bleeding (AUB), as well as to calculate the risk of endometrial cancer in women with or without AUB.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Neoplasms | Endometrial Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Hysteroscopy | Diagnostic Test | — | UNRESOLVED |
| Ultrasound | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Breast cancer patients with abnormal uterine bleeding
- description
- * Transvaginal ultrasonography * Outpatient Hysteroscopy
- interventionNames
- Diagnostic Test: Ultrasound
- Diagnostic Test: Hysteroscopy
- label
- Breast cancer patients without abnormal uterine bleeding
- description
- * Transvaginal ultrasonography * Outpatient Hysteroscopy
- interventionNames
- Diagnostic Test: Ultrasound
- Diagnostic Test: Hysteroscopy
Primary outcomes (2)
- measure
- Endometrial cancer rate
- timeFrame
- 1 month after admission
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 43 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * In case of AUB: ultrasonographic endometrial thickness \>5 mm at transvaginal ultrasound * In case of non-AUB group ultrasonographic suspicion of endometrial or myometrial abnormalities Exclusion Criteria: * severe comorbidities (cardiovascular, metabolic, endocrine, and immunological disorders) * receiving any other form of pharmacologic therapy
References
Publications (0)
Data not yet available
No reference posted for this study.